ClassID:

109306

C12N2501/17 - CPC Classification

Classification description:

Active agents used in cell culture processes, e.g. differentation; Growth factors Angiopoietin

Recent Application in this class:
#1
20260152717
2026-06-04

METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS

#2
20250230404
2025-07-17

METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN

#3
20240368562
2024-11-07

Regeneration of a Functional Pulmonary Vascular Bed

#4
20220184182
2022-06-16

PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE

#5
20220033772
2022-02-03

FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS

#6
20210355437
2021-11-18

FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS

#7
20210301252
2021-09-30

METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS

#8
20210230540
2021-07-29

UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF

#9
20210196761
2021-07-01

Multilayered cell sheet of cardiac stem cells and method of preparing the same

#10
20210128688
2021-05-06

Q-peptide hydrogel promotes immune modulation and macrophage differentiation

#11
20200354685
2020-11-12

Regeneration of a Functional Pulmonary Vascular Bed

#12
20200325443
2020-10-15

METHOD OF INDUCING OR IMPROVING WOUND HEALING PROPERTIES OF MESENCHYMAL STEM CELLS

#13
20200268849
2020-08-27

Peptides and compositions for treatment of joint damage

#14
20200157500
2020-05-21

Stem cell-derived skin precursor cell culture medium and preparation method therefor

#15
20200149005
2020-05-14

Method of autologous primary hair follicles preparation in 3D culture

#16
20200129559
2020-04-30

PD-L1 expressing hematopoietic stem cells and uses

#17
20200085878
2020-03-19

PD-L1 expressing hematopoietic stem cells and uses

#18
20200079830
2020-03-12

Peptides and compositions for treatment of joint damage

#19
20190330593
2019-10-31

LILRB2 AND NOTCH-MEDIATED EXPANSION OF HEMATOPOIETIC PRECURSOR CELLS

#20
20190290803
2019-09-26

3D vascularized human ocular tissue for cell therapy and drug discovery

#21
20190161527
2019-05-30

Peptides and compositions for treatment of joint damage

#22
20190099450
2019-04-04

PD-L1 expressing hematopoietic stem cells and uses

#23
20190070337
2019-03-07

Multilayered cell sheet of neural crest stem cells and method of preparing the same

#24
20180298329
2018-10-18

Early vascular cell population

#25
20180214487
2018-08-02

PD-L1 EXPRESSING HEMATOPOIETIC STEM CELLS AND USES

#26
20180194823
2018-07-12

Peptides and compositions for treatment of joint damage

#27
20170349880
2017-12-07

Adoptive immunotherapy for treating cancer

#28
20170327552
2017-11-16

Peptides and compositions for treatment of joint damage

#29
20170260508
2017-09-14

LILRB2 and notch-mediated expansion of hematopoietic precursor cells

#30
20170252407
2017-09-07

Peptides and compositions for treatment of joint damage

#31
20170073645
2017-03-16

Regeneration of a functional pulmonary vascular bed

#32
20170029772
2017-02-02

Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix

#33
20160376337
2016-12-29

Peptides and compositions for treatment of joint damage

#34
20160244491
2016-08-25

Peptides and compositions for treatment of joint damage

#35
20160075997
2016-03-17

KIT OF MEDIUM OF INDUCING AND AMPLIFYING HEMATOPOIETIC STEM CELLS

#36
20160008433
2016-01-14

Peptides and compositions for treatment of joint damage

#37
20150315545
2015-11-05

Method of rapidly inducing large-scale and high-purity mesenchymal stem cells to transdetermine into hematopoietic stem cells

#38
20150166962
2015-06-18

Hydrogel-based vascular lineage cell growth media and uses thereof

#39
20140273220
2014-09-18

Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix

#40
20120225814
2012-09-06

Hydrogel-based vascular lineage cell growth media and uses thereof

#41
20110286985
2011-11-24

Method of treatment using organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1α

#42
20110196343
2011-08-11

Methods for expansion and analysis of cultured hematopoietic stem cells

#43
20110117061
2011-05-19

Ex vivo expansion of human hematopoietic stem cells

#44
20110105393
2011-05-05

METHODS FOR PROMOTING STEM CELL PROLIFERATION AND SURVIVAL

#45
20110059057
2011-03-10

Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous HIF-1a

#46
20090169528
2009-07-02

Keratinocytes expressing exogenous angiogenic growth factors

#47
20090117087
2009-05-07

METHODS AND COMPOSITIONS FOR PRINTING BIOLOGICALLY COMPATIBLE NANOTUBE COMPOSITES OF AUTOLOGOUS TISSUE

#48
20070020757
2007-01-25

Methods for expansion and analysis of cultured hematopoietic stem cells

#49
20060024825
2006-02-02

METHOD OF PROMOTING EXPANSION OF STEM CELLS

#50
20050013807
2005-01-20

Organotypically cultured skin tissue comprising NIKS cells that express exogenous HIF-1a